The keystones of quality clinical trial results.
Axio provides a full range of statistical analysis and programming capabilities spanning preclinical through Phase 4 clinical development.
Our highly trained PhD/MS biostatisticians collaborate with our clients on optimal design, implementation, evaluation, and reporting on all phases of the clinical development program.
Our specialists can also provide statistical guidance and representation at FDA meetings and FDA advisory meetings.
Our services spanning preclinical through Phase 4 clinical trials include:
- Trial design
- Statistical analysis plan development
- Final statistical plan production
- Protocol development/review
- Sample size calculations for trials or assay validations
- Randomization plan design
- Epidemiological and observational studies
- Instrument development and validation
- SAS programming